beinaglutide vs semaglutide Recombinant human GLP-1 regulates lipid metabolism of adipose tissues in diet-induced obese mice: iScience Glucagon-like peptide 1(GLP-1) receptor agonists

Shortness of breath, or dyspnea, is not listed as a common or characteristic adverse effect of GLP-1 receptor agonists in FDA-approved prescribing information

The phase II clinical study, Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID2), yielded no significant therapeutic effects

The eating behavior data at week 36 actually showed stronger effects than at week 24 for the 8mg and 12mg groups

The medications, which were initially intended to treat Type 2 diabetes, have seen a 700% increase in usage between 2019 and 2023 in the United States due to their powerful weight-loss effects as they mimic the natural GLP-1 hormone that regulates blood sugar and appetite, while also boosting insulin production, slow digestion and having the patient feel full longer